Ultime notizie per PLDT (NYSE:PHI) Azioni

PLDT

PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line, and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.

PLDT Inc

PHI Group Inc

Phinia Inc

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corp

PHASE HOLOGRAPHIC IMAGNG by Phase Holographic Imaging PHI AB

The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">PLDT Inc ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHI#NYSE">PHI</a>)</h3>
<ul>
<li>On March 27, PLDT filed 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission. The company's stock fell around 12% over the past month and has a <a href="https://www.benzinga.com/quote/PHI">52-week low of $22.01</a>.</li>
<li>RSI Value: 25.90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>PHI Price Action: Shares of PLDT fell 1.8% to close at $22.90 on Monday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent111224&amp;t=be2bearmibe3na1">latest PHI news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent111224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="903" height="807" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040123/image-113.png" alt="" class="wp-image-642311" style="width:677px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040123/image-113.png 903w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040123/image-113-300x268.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040123/image-113-768x686.png 768w" sizes="(max-width: 903px) 100vw, 903px" /></a></figure>
<h3 class="wp-block-heading">Liberty Latin America Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILA#NASDAQ">LILA</a>)&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Nov. 6, Liberty Latin America reported worse-than-expected third-quarter revenue results. CEO Balan Nair commented, &#8220;We are continuing our strategy to connect communities and drive broadband and postpaid mobile penetration across our markets. We are encouraged by our transformation programs, which are increasingly gaining momentum and enabling us to connect with our customers through their channels of choice.&#8221; The company's stock fell around 24% over the past five days and <a href="https://www.benzinga.com/quote/LILA">has a 52-week low</a> of $5.90.</li>
<li>RSI Value: 24.04</li>
<li>LILA Price Action: Shares of Liberty Latin America fell 2% to close at $7.46 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent111224&amp;t=be2bearmibe3na1">trend in LILA stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent111224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="885" height="810" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040219/image-114.png" alt="" class="wp-image-642315" style="width:650px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040219/image-114.png 885w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040219/image-114-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040219/image-114-768x703.png 768w" sizes="(max-width: 885px) 100vw, 885px" /></a></figure>
<h3 class="wp-block-heading">Telefonica SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEF#NYSE">TEF</a>)</h3>
<ul>
<li>On Nov. 7, Telefonica posted third-quarter sales of $11.02 billion down from $11.23 billion in the year-ago period. The company's stock fell around 9% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/DHC">low of $3.82</a>.</li>
<li>RSI Value: 21.28</li>
<li>TEF Price Action: Shares of Telefonica fell 2% to close at $4.37 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent111224&amp;t=be2bearmibe3na1">breakout in TEF shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent111224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="897" height="435" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040317/image-115.png" alt="" class="wp-image-642317" style="width:674px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040317/image-115.png 897w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040317/image-115-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/12040317/image-115-768x372.png 768w" sizes="(max-width: 897px) 100vw, 897px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41877638/jim-cramer-tech-stock-go-to-160-recommends-buying-dominos-pizza">Jim Cramer: This Tech Stock Can &#8216;Go To 160,&#8217; Recommends Buying Domino&#8217;s Pizza</a></li>
</ul>

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

LILA

Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio In Q4

PLDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHI#NYSE">PHI</a>) reported quarterly earnings of $0.78 per share. This is a 1.3 percent increase over earnings of $0.77 per share from the same period last year. The company reported $933.46 million in sales this quarter. This is a 0.16 percent decrease over sales of $934.92 million the same period last year.

Earnings

PLDT Q3 EPS $0.78 Up From $0.77 YoY, Sales $933.46M Down From $934.92M YoY

ABOS

ABSI

ACNT

ACTG

AENT

AGEN

AIOT

AIRG

ALIT

ALTG

AMBC

AMPS

AMTX

APEI

AREB

ARIS

ARMN

ATRA

AUTL

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AXSM

AZTA

BHIL

BLDE

BLFS

BLTE

The Beachbody Company, Inc. Class A Common Stock

BODI

BRTX

BTMD

BTTR

BWAY

BXSL

BZFD

CAMT

CART

CATX

CAVA

CBAT

CBLL

CCLD

CGEN

CHGG

CHMI

CLSD

CNNE

CRNX

CRON

CRVS

CRWS

CVAC

CXAI

DAVA

DAVE

DRCT

DYAI

EARN

EGAN

ELMD

ETON

EVCM

EVGO

EYEN

FENG

FGEN

FIHL

FLNG

FOUR

FTCI

GENI

GENK

GMGI

GOVX

GRAL

GRDN

GROV

GRPN

GRVY

Earnings Scheduled For November 12, 2024

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.
Shares of ACADIA Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acad#NASDAQ">ACAD</a>) fell sharply in today&rsquo;s pre-market trading after the company reported the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia did not <a href="https://www.benzinga.com/quote/ACAD/news">meet the primary endpoint</a>.
ACADIA Pharmaceuticals shares dipped 17.4% to $19.93 in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>Power &amp; Digital Infrastructure Acquisition II Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xpdb#NASDAQ">XPDB</a>) shares tumbled 12.6% to $25.57 in pre-market trading after surging 181% on Monday.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) shares fell 5.9% to $9.16 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Aeva Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeva#NASDAQ">AEVA</a>) shares declined 5.4% to $1.23 in pre-market trading. Aeva said it expects a 1-for-5 reverse stock split of its outstanding shares of common stock will be effective as of March 18, 2024.</li>
<li>PLDT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>) fell 3.8% to $25.95 in pre-market trading after jumping over 16% on Monday.</li>
<li>NextNav Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nn#NASDAQ">NN</a>) declined 3.6% to $5.07 in pre-market trading. NextNav shares jumped 35% on Monday after the company announced it signed an agreement to acquire spectrum licenses covering an additional 4 MHz in the lower 900 MHz band.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) shares fell 3.2% to $2.72 in pre-market trading. Lexicon shares surged over 29% on Monday after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.</li>
<li>Asana, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asan#NYSE">ASAN</a>) shares fell 2.4% to $18.35 in pre-market trading following fourth-quarter results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/03/37584146/top-5-risk-off-stocks-that-may-plunge-this-quarter"> Top 5 Risk Off Stocks That May Plunge This Quarter </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Penny Stocks

Small Cap

Movers

ACAD

AEVA

ASAN

ASNA

LXRX

OCUL

XPDB

ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

As of Jan. 12, 2024, four stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Beasley Broadcast Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbgi#NASDAQ">BBGI</a>)</h3>
<ul>
<li>On Nov. 1, Beasley Broadcast posted downbeat quarterly results. Caroline Beasley, Chief Executive Officer, said, &ldquo;Beasley&rsquo;s third quarter financial results reflect the well-publicized economic challenges and continued advertising market softness which we outlined in the prior quarters. While we saw sequential month-over-month improvement in our advertising revenue performance from August to September, our net revenues for the 2023 third quarter decreased 5.8% year-over-year, or 3.2% when excluding the year-over-year decrease in political advertising revenue of $1.9 million.&rdquo; The company&rsquo;s stock jumped around 7% over the past month and has a <a href="https://www.benzinga.com/quote/BBGI">52-week high of $1.39 </a>.</li>
<li>RSI Value: 75.48</li>
<li>BBGI Price Action: Shares of Beasley Broadcast fell 1.9% to close at $0.8050 on Thursday.</li>
</ul>
<h3>Fluent, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flnt#NASDAQ">FLNT</a>)</h3>
<ul>
<li>On Nov. 14, 2023, Fluent posted weak quarterly results. Don Patrick, Fluent&rsquo;s Chief Executive Officer, commented, &ldquo;Our third quarter results clearly reflect our post-FTC settlement transition and the subsequent impact on our financials related to the business segments we have deemed non-strategic in the future.&rdquo; The company&rsquo;s stock gained around 45% over the past month and <a href="https://www.benzinga.com/quote/FLNT"> has a 52-week high </a> of $1.81.</li>
<li>RSI Value: 78.11</li>
<li>FLNT Price Action: Shares of Fluent fell 2.5% to close at $0.7401 on Thursday.</li>
</ul>
<h3>Reading International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdi#NASDAQ">RDI</a>)</h3>
<ul>
<li>On Nov. 14, Reading International posted a narrower quarterly loss. President and Chief Executive Officer, Ellen Cotter said, &ldquo;Building on the success of our strong second quarter, the Company continued that positive momentum into the third quarter by delivering global total revenues of $66.6 million, which grew by 30% compared to the third quarter of 2022.&rdquo; The company&rsquo;s stock jumped around 13% over the past month and has a <a href="https://www.benzinga.com/quote/RDI"> 52-week high </a> of $3.72.</li>
<li>RSI Value: 70.78</li>
<li>RDI Price Action: Shares of Reading International rose 1% to close at $1.98 on Thursday.</li>
</ul>
<h3>PLDT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>)</h3>
<ul>
<li>The company&rsquo;s stock has a 52-week high is $27.98.</li>
<li>RSI Value: 70.60</li>
<li>PHI Price Action: Shares of PLDT fell 1% to close at $22.94 on Thursday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/24/01/36606238/citigroup-bank-of-america-and-3-stocks-to-watch-heading-into-friday"> Citigroup, Bank of America And 3 Stocks To Watch Heading Into Friday </a>

Short Ideas

BBGI

FLNT

Top 4 Tech And Telecom Stocks That May Crash In January

<ul>
<li>Philippines&rsquo; largest telecommunications firm&nbsp;PLDT Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>), weighed the sale of a significant minority stake in its data center assets as it battled fallout from a spending scandal.</li>
<li>PLDT eyed selling telecom towers in 2023 to offset the impact of the capital spending exceeding its budget, Bloomberg&nbsp;<a class="editor-rtfLink" href="https://www.bloomberg.com/news/articles/2023-02-23/pldt-said-to-weigh-data-center-stake-sale-after-spending-overrun?srnd=technology-vp&amp;sref=TBDibEcD" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">reports</a>&nbsp;citing familiar sources.&nbsp;</li>
<li>PLDT consulted financial advisers as it weighs bringing in an investor into its data center business.&nbsp;</li>
<li>A transaction could value the business at $700 million - $800 million.</li>
<li>A partner would help the company raise cash and further develop its business.&nbsp;</li>
<li>In 2022, PLDT sold half its telecom towers for about $1.3 billion in two portfolios to Edotco Group Sdn. and EdgePoint Infrastructure units. It&rsquo;s also considering selling a few thousand towers for about $300 million.</li>
<li>PLDT had weighed a sale of the data centers in 2021 before putting the process on hold.</li>
<li>PLDT did not consider a stake sale &ldquo;as of the moment,&rdquo; Mitch Locsin, PLDT&rsquo;s first vice president and head of the enterprise, said in response to a Bloomberg query. He added that the company&rsquo;s information technology unit focused on completing its hyperscaler 11th data center.</li>
<li>PLDT grappled with local investigations and a U.S. shareholder lawsuit related to a 48 billion peso ($871 million) spending overrun discovered in an internal audit last year.</li>
<li>Price Action:&nbsp;PHI shares traded lower by 0.77% at $24.34 on the last check Thursday.</li>
</ul>

Asset Sales

Media

PLDT Explores Stake Sale In Data Center Assets To Raise Cash For Business Development

<h3>Understanding Value Stocks</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Benzinga Insights has compiled a list of value stocks in the communication services sector that may be worth watching:</h2>
<ol>
<li>Gogo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) - P/E: 6.96</li>
<li>Urban One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONEK#NASDAQ">UONEK</a>) - P/E: 5.7</li>
<li>Outbrain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OB#NASDAQ">OB</a>) - P/E: 5.74</li>
<li>JOYY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>) - P/E: 4.92</li>
<li>PLDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHI#NYSE">PHI</a>) - P/E: 8.37</li>
</ol>
Gogo saw a decrease in earnings per share from 0.17 in Q2 to $0.15 now. Urban One's earnings per share for Q3 sits at $0.08, whereas in Q2, they were at 0.28. Outbrain has reported Q3 earnings per share at $-0.1, which has increased by 47.37% compared to Q2, which was -0.19. Most recently, the company reported a dividend yield of 4.61%, which has decreased by 1.91% from last quarter's yield of 6.52%.
This quarter, JOYY experienced an increase in earnings per share, which was $0.65 in Q2 and is now $0.96. The company's most recent dividend yield sits at 7.52%, which has increased by 1.23% from 6.29% last quarter. 
This quarter, PLDT experienced an increase in earnings per share, which was $0.67 in Q2 and is now $0.87. The company's most recent dividend yield sits at 8.77%, which has increased by 5.4% from 3.37% last quarter. 
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

GOGO

UONEK

5 Value Stocks In The Communication Services Sector

The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>The Liberty SiriusXM Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lsxmk#NASDAQ">LSXMK</a>)</h3>
<ul>
<li>Liberty Media said Courtnee Chun, currently Chief Portfolio Officer, will transition to a Senior Advisor role effective January 3, 2023. The company&rsquo;s stock has a <a href="https://www.benzinga.com/news/earnings/22/05/27048973/liberty-media-boosts-share-buyback-post-q1-liberty-siriusxm-clocks-6-revenue-growth-to-2-2b">52-week low of $34.34 </a>.</li>
<li>RSI Value: 29.68</li>
<li>LSXMK Price Action: Shares of Liberty SiriusXM rose 1.2% to settle at $39.02 on Wednesday.</li>
</ul>
<h3>
PLDT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>)</h3>
<ul>
<li>PLDT&rsquo;s stock dropped around 18% over the past month. The company&rsquo;s <a href="https://www.benzinga.com/news/22/12/30133347/why-cosmos-health-shares-are-trading-lower-by-around-60-here-are-79-stocks-moving-in-mondays-mid-day"> stock has a 52-week low </a> of $20.20.</li>
<li>RSI Value: 27.80</li>
<li>PHI Price Action: Shares of PLDT gained 9.2% to close at $22.66 on Wednesday and lost 2.4% in after-hours trading.</li>
</ul>
<h3>
Cinemark Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cnk#NYSE">CNK</a>)</h3>
<ul>
<li>Benchmark maintained Cinemark with a Buy and lowered the price target from $22 to $17. The company&rsquo;s stock has a 52-week <a href="https://www.benzinga.com/news/earnings/22/11/29571137/cinemark-clocks-positive-operating-income-in-q3-as-recovery-kicks-in-registers-50-revenue-growth"> low of $8.90.</a></li>
<li>RSI Value: 27.13</li>
<li>CNK Price Action: Shares of Cinemark Holdings fell 2.8% to close at $8.95 on Wednesday and gained 1.1% in after-hours trading.</li>
</ul>
<h3>
The Marcus Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mcs#NYSE">MCS</a>)</h3>
<ul>
<li>Marcus Hotels &amp; Resorts. <a href="https://www.benzinga.com/markets/penny-stocks/22/12/30059460/short-interest-sector-focus-communication-services-sector"> announced the sale of </a> Skirvin Hilton for $36.75 million. The company&rsquo;s 52-week low is $13.41.</li>
<li>RSI Value: 29.29</li>
<li>MCS Price Action: Shares of Marcus dropped 1% to close at $14.00 on Wednesday.</li>
</ul>
<h3>
AST SpaceMobile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asts#NASDAQ">ASTS</a>)</h3>
<ul>
<li>AST SpaceMobile and NASA signed a joint agreement to improve spaceflight safety. The company <a href="https://www.benzinga.com/news/22/11/29904240/ast-spacemobile-raises-75m-via-equity-offering"> has a 52-week low </a> of $3.63.</li>
<li>RSI Value: 26.06</li>
<li>ASTS Price Action: Shares of AST SpaceMobile gained 2.5% to settle at $3.77 on Wednesday, and added 0.3% in the after-hours trading session.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/earnings/22/12/30170537/cnn-fear-greed-index-remains-in-fear-zone-despite-dow-jumping-over-500-points"> CNN Fear &amp; Greed Index Remains In &#39;Fear&#39; Zone Despite Dow Jumping Over 500 Points </a>

ASTS

LSXMK

Why Cinemark, Liberty SiriusXM And Other Oversold Majors In The Communication Services Sector Look Promising

WIIM

CHTR

EVER

GROM

IPDN

LFLY

LILAK

LTRPB

MGAM

MSGS

NFLX

PINS

SNAP

STRY

TRKA

Shares of several companies in the broader communications, media & entertainment industry are trading higher amid overall market weakness as stocks rebound following recent weakness.

BHAT

BMBL

DLPN

FOXA

ICLK

LSXMB

LYLT

MTCH

NCMI

NXST

ONFO

PLTK

SKLZ

VTEX

WLYB

YNDX

Shares of several companies in the broader communication, media and entertainment industry are trading lower amid overall market weakness as investors continue to weigh recession fears following last Wednesday's Fed decision, in which the Fed raised rates and increased its federal funds rate projections.

<h3>Gainers</h3>
<ul>
<li>Madrigal Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdgl#NASDAQ">MDGL</a>) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.</li>
<li>Axcella Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axla#NASDAQ">AXLA</a>) shares rose 153% to $0.4105. Axcella Health shares dipped 63% on Friday after SVB Leerink downgraded the stock from Outperform to Market Perform and lowered its price target from $6 to $2.</li>
<li>Camber Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cei#NYSE">CEI</a>) shares climbed 103% to $0.1257 after the company announced an anticipated effective date of December 21, 2022 for its previously-announced 1-for-50 reverse stock split.</li>
<li>Qumu Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qumu#NASDAQ">QUMU</a>) gained 98.2% to $0.8722 after Enghouse Systems announced it will acquire the company for $0.90 per share in cash.</li>
<li>AirNet Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ante#NASDAQ">ANTE</a>) jumped 64% to $1.93.</li>
<li>Viking Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vktx#NASDAQ">VKTX</a>) shares climbed 61% to $6.48 in sympathy with Madrigal Pharmaceuticals which announced a successful trial for liver fibrosis.</li>
<li>Nogin, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nogn#NASDAQ">NOGN</a>) rose 44% to $0.72 after declining 39% on Friday. Nogin&rsquo;s Co-CEO and President Jonathan Huberman recently acquired a total of 19,300 shares at an average price of $0.90.</li>
<li>Soleno Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slno#NASDAQ">SLNO</a>) surged 39% to $1.26 after the company announced a financing commitment for up to $60 million.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tern#NASDAQ">TERN</a>) rose 39% to $9.55 in sympathy with Madrigal Pharmaceuticals, which gained after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.</li>
<li>Caravelle International Group (NASDAQ: CACO) gained 38.8% to $5.83.</li>
<li>Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) climbed 38% to $0.3410 after dipping around 70% on Friday. Agrify announced pricing of a public offering.</li>
<li>Innate Pharma S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipha#NASDAQ">IPHA</a>) rose 37% to $2.6032 after the company and Sanofi announced an expansion of their collaboration for natural killer cell therapeutics in oncology. Innate will receive a &euro;25 million upfront payment.</li>
<li>Greenidge Generation Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gree#NASDAQ">GREE</a>) rose 30.3% to $0.3260 after dropping 39% on Friday.</li>
<li>Cazoo Group Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/czoo#NYSE">CZOO</a>) rose 24.4% to $0.1618. Cazoo recently sold its Spanish subscription business, Swipcar, to Renting Finders S.L.</li>
<li>Otonomy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otic#NASDAQ">OTIC</a>) rose 24.1% to $0.1118 after dropping over 21% on Friday.</li>
<li>Cerevel Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cere#NASDAQ">CERE</a>) gained 24% to $31.53 after the company said its Emraclidine Ambulatory Blood Pressuring Monitoring Trial did not cause an increase in blood pressure.</li>
<li>Aspen Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aspu#NASDAQ">ASPU</a>) gained 23.3% to $0.2833. Aspen Group recently reported better-than-expected Q2 sales results.</li>
<li>iHuman Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ih#NYSE">IH</a>) gained 21.2% to $2.80.</li>
<li>Anebulo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aneb#NASDAQ">ANEB</a>) gained 20.3% to $2.84.</li>
<li>Future FinTech Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftft#NASDAQ">FTFT</a>) jumped 19.1% to $0.5480.</li>
<li>Celcuity Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celc#NASDAQ">CELC</a>) gained 19% to $11.91.</li>
<li>AppHarvest, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apph#NASDAQ">APPH</a>) rose 18.7% to $0.5563.</li>
<li>Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) rose 17.8% to $0.1178 after dropping around 6% on Friday.</li>
<li>Bird Global, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brds#NYSE">BRDS</a>) gained 17.7% to $0.1765.</li>
<li>Professional Diversity Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipdn#NASDAQ">IPDN</a>) surged 17.6% to $0.7771.</li>
<li>Argo Blockchain plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbk#NASDAQ">ARBK</a>) rose 17.5% to $0.45 after declining 21% on Friday.</li>
<li>Horizon Global Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hzn#NYSE">HZN</a>) gained 16.7% to $0.70.</li>
<li>PainReform Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prfx#NASDAQ">PRFX</a>) gained 14% to $0.57.</li>
<li>Akili, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akli#NASDAQ">AKLI</a>) shares rose 14% to $1.14 after dipping 35% on Friday.</li>
<li>CI&amp;T Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cint#NYSE">CINT</a>) gained 12.8% to $5.89. CI&amp;T said that it has become an Amazon Web Services (AWS) Advanced Tier Services Partner within the AWS Partner Network.</li>
<li>Coeptis Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coep#NASDAQ">COEP</a>) rose 11.6% to $1.15 after dropping 36% on Friday.</li>
<li>Reading International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdib#NASDAQ">RDIB</a>) gained 10.2% to $19.77.</li>
<li>17 Education &amp; Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yq#NASDAQ">YQ</a>) rose 10.2% to $1.8286 after jumping 29% on Friday. 17 Education &amp; Technology recently posted a Q3 loss of $0.01 per share.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) gained 10% to $3.9699.</li>
<li>Perfect Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/perf#NYSE">PERF</a>) gained 8.4% to $7.10.</li>
<li>ObsEva SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/obsv#NASDAQ">OBSV</a>) rose 6.6% to $0.1472. The company reported dismissal of moratorium proceedings.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Cosmos Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cosm#NASDAQ">COSM</a>) shares dipped 59.6% to $9.30 after the company reported pricing of $32.5 million registered direct offering and concurrent private placement priced at-the-market.</li>
<li>Forward Pharma A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fwp#NASDAQ">FWP</a>) fell 38.7% to $1.60. Forward Pharma announced expected delisting of its American Depositary Shares from the Nasdaq Capital Market.</li>
<li>Scopus BioPharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/scps#NASDAQ">SCPS</a>) fell 34.7% to $0.0556.</li>
<li>NantHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nh#NASDAQ">NH</a>) fell 30.7% to $3.95. NantHealth recently announced a 1-for-15 reverse stock split.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zvsa#NASDAQ">ZVSA</a>) dropped 25.1% to $2.4109.</li>
<li>VistaGen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtgn#NASDAQ">VTGN</a>) declined 25% to $0.1092. VistaGen Therapeutics recently announced the FDA granted Fast Track designation for the development of PH10 for the treatment of major depressive disorder.</li>
<li>Invacare Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ivc#NYSE">IVC</a>) dropped 25% to $0.4499.</li>
<li>Healthcare Triangle, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcti#NASDAQ">HCTI</a>) fell 23.7% to $0.2364.</li>
<li>Lanvin Group Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lanv#NYSE">LANV</a>) fell 23% to $7.70 after surging 31% on Friday.</li>
<li>Neptune Wellness Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nept#NASDAQ">NEPT</a>) dropped 22.8% to $0.27. Neptune Wellness Solutions reported a net loss of $37.3 million for the fiscal second quarter 2023 versus a year-ago net loss of $12.1 million. Its net sales revenue declined to $12 million from $12.5 million.</li>
<li>PLDT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>) dropped 22.4% to $20.81.</li>
<li>BiomX Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phge#NYSE">PHGE</a>) shares fell 22.1% to $0.1720 after jumping 63% on Friday. BiomX, last month, posted a Q3 loss of $0.23 per share.</li>
<li>Tellurian Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tell#NASDAQ">TELL</a>) dropped 20.3% to $1.93.</li>
<li>Gossamer Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goss#NASDAQ">GOSS</a>) declined 20.3% to $2.1750.</li>
<li>Akero Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akro#NASDAQ">AKRO</a>) fell 18.9% to $38.10.</li>
<li>Intercept Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icpt#NASDAQ">ICPT</a>) fell 18.8% to $12.45. STAT News reporter Adam Feuerstein tweets &quot;Intercept Pharmaceuticals Down 10% Because OCA&#39;s Future In NASH Looks Bleaker. Investors Really Want Intercept To Ditch NASH And Focus On The Approved PBC Indication.&quot;</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) dropped 17.9% to $0.5598.</li>
<li>Meihua International Medical Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mhua#NASDAQ">MHUA</a>) fell 17.8% to $9.28.</li>
<li>Nexa Resources S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nexa#NYSE">NEXA</a>) dropped 17.8% to $5.51.</li>
<li>Altimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alt#NASDAQ">ALT</a>) fell 17.2% to $9.51.</li>
<li>89bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etnb#NASDAQ">ETNB</a>) fell 16.8% to $8.78.</li>
<li>Vivani Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vani#NASDAQ">VANI</a>) dropped 16.7% to $0.8578.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) fell 16.5% to $0.1773 after jumping 22% on Friday.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) dropped 15.7% to $4.24.</li>
<li>Synaptogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpx#NASDAQ">SNPX</a>) fell 14.3% to $1.0228. Synaptogenix shares dropped 75% on Friday after the company announced results from its Phase 2 clinical trial of Bryostatin-1 for the treatment of advanced Alzheimer&#39;s disease, in which the primary endpoint was not met with statistical significance.</li>
<li>Cue Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlth#NASDAQ">HLTH</a>) fell 14.2% to $2.5050.</li>
<li>C4 Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccc#NASDAQ">CCCC</a>) dropped 14.1% to $6.32.</li>
<li>Seer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seer#NASDAQ">SEER</a>) declined 13.6% to $5.40.</li>
<li>New Pacific Metals Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newp#NYSE">NEWP</a>) fell 13.4% to $2.50.</li>
<li>Mondee Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mond#NASDAQ">MOND</a>) dropped 13.4% to $10.61.</li>
<li>Arcellx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aclx#NASDAQ">ACLX</a>) fell 12.2% to $27.97.</li>
<li>Richardson Electronics, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rell#NASDAQ">RELL</a>) dropped 11.6% to $21.66.</li>
<li>Gevo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gevo#NASDAQ">GEVO</a>) fell 10.7% to $1.7950.</li>
<li>Cinemark Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cnk#NYSE">CNK</a>) fell 10.5% to $9.69.</li>
<li>Domo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/domo#NASDAQ">DOMO</a>) dropped 10.5% to $14.81. Morgan Stanley maintained Domo with an Overweight and lowered the price target from $51 to $24.</li>
<li>Mersana Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrsn#NASDAQ">MRSN</a>) dipped 10.5% to $5.82.</li>
<li>ChargePoint Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chpt#NYSE">CHPT</a>) declined 9.6% to $9.45.</li>
<li>MasterBrand, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mbc#NYSE">MBC</a>) fell 9.5% to $8.42 after jumping over 20% on Friday.</li>
<li>Relay Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rlay#NASDAQ">RLAY</a>) dropped 9.4% to $15.44.</li>
<li>Melco Resorts &amp; Entertainment Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlco#NASDAQ">MLCO</a>) fell 9.3% to $10.90.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) dropped 8.3% to $4.8650. AMC Entertainment announced Monday that it has raised $162 million from its AMC Preferred Equity Units since launching the stock just a few months ago.</li>
<li>Ardelyx, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ardx#NASDAQ">ARDX</a>) fell 7.9% to $1.8050 after the company provided an update regarding the appeal to the Complete Response Letter for the New Drug Application for XPHOZAH.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) fell 7.8% to $0.2787. Mullen Automotive recently announced it received a purchase order from Randy Marion Automotive Group for 6,000 Class 1 EV cargo vans.</li>
</ul>
Also check this out <a href="https://www.benzinga.com/trading-ideas/long-ideas/22/12/30127835/over-13-million-bet-on-this-biotechnology-stock-check-out-these-4-stocks-insiders-are-bu"> Over $13 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying</a>.

Intraday Update

ACLX

AGFY

AKLI

AKRO

ANEB

ANTE

APPH

ARBK

ARDX

ASPU

AXLA

BRDS

CCCC

CELC

CERE

CHPT

CINT

COEP

COSM

CVNA

CZOO

DOMO

ETNB

FTFT

GEVO

GOSS

GREE

HCTI

HLTH

ICPT

IPHA

LANV

Citigroup Financial 300% Minupon Princ Protected Nts for Russell 2000 Index

MDGL

MHUA

MINM

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session

Comments

PLDT

Notizie

Ultime notizie per PLDT (NYSE:PHI) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO